The Autralian biotech industry continues to mature and grow rapidly. Australian biotechs have been performing solidly in terms of raising capital over the 2006/2007 financial year, helped by the transitioning pipeline of a number of companies in anticipation of positive outcomes.
CITATION STYLE
Watkinson, N. (2007, September). New Opportunities. EBR - European Biopharmaceutical Review. https://doi.org/10.7810/9781988587844_7
Mendeley helps you to discover research relevant for your work.